[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100555788":3},{"organization":4,"outcomesModule":7,"designInfo":39,"detailedDescription":38,"studyPopulation":38,"armGroups":45,"interventions":58,"overallOfficials":69,"centralContacts":73,"locations":82,"responsibleParty":99,"collaborators":102,"id":106,"slug":38,"hasResults":107,"nctId":108,"briefTitle":109,"officialTitle":110,"acronym":38,"eligibilityCriteria":111,"healthyVolunteers":107,"sex":112,"minAge":113,"maxAge":114,"enrollmentInfo":115,"targetDuration":38,"studyType":118,"phases":119,"briefSummary":121,"conditions":122,"keywords":124,"overallStatus":84,"whyStopped":38,"lastUpdateSubmitDate":128,"lastUpdatePostDateStruct":129,"startDateStruct":132,"completionDateStruct":134,"leadSponsor":136,"locationsCount":137},{"fullName":5,"class":6},"Children's Hospital Los Angeles","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":38},[9],{"measure":10,"description":11,"timeFrame":12},"Mean change in Time in Range (TIR) from baseline to 6 months","Change in % glucose TIR (70-180 mg\u002FdL)","Baseline to 6 months",[14,17,21,25,29,33,36],{"measure":15,"description":16,"timeFrame":12},"Mean change in Hemoglobin A1c (HbA1c) from baseline to 6 months","Change in Hemoglobin A1c",{"measure":18,"description":19,"timeFrame":20},"Mean change in CGM metrics measured by CGM readings","% Glucose Time Below Range (\\\u003C70mg\u002FdL), % Glucose Time Above Range (\\>180mg\u002FdL), % Glucose Variability (coefficient of variation, CV)","Week 4 & 6 months",{"measure":22,"description":23,"timeFrame":24},"Change in perceived diabetes distress at baseline, week 4 & 6 months","The Type 2 Diabetes Distress Assessment System (T2-DDAS) measures how much overall emotional distress is due to diabetes. Respondents are given statements about diabetes-related issues and indicate on a 5-point Likert scale (0 = not a problem, 1 = minor problem, 2 = moderate problem, 3 = somewhat serious problem, 4 = serious problem) the degree to which the statements are a problem. Increasing scores denote increased burden perceived.","Baseline, Week 4 & 6 months",{"measure":26,"description":27,"timeFrame":28},"Change in perceived diabetes family responsibility at baseline, week 4 & 6 months","The Diabetes Family Responsibility Questionnaire (DFRQ) is a 14-item validated survey assessing parental and child involvement in various diabetes management tasks. Youth and caregivers report on a 3-point scale (1=child, 2=equal, 3=parent) who is responsible for a given diabetes task. Higher scores indicate more parental involvement in diabetes management.","Baseline, week 4 & 6 months",{"measure":30,"description":31,"timeFrame":32},"Average number of diabetes educator hours used per study participant at week 4 & 6 months.","Number of hours spent in diabetes education","Week 4 and 6 months",{"measure":34,"description":35,"timeFrame":20},"Mean change in perceived benefits of Continuous Glucose (CGM) Monitor use","Name of questionnaire: Adolescent Benefits and Burdens of CGM Survey - BenCGM \\& BurCGM. Participants answer each question on a scale of Strong Disagree, Disagree, Neutral, Agree, Strongly Agree.",{"measure":37,"description":35,"timeFrame":20},"Mean change in perceived burden of Continuous Glucose Monitor (CGM) use",null,{"allocation":40,"interventionModel":41,"interventionModelDescription":38,"primaryPurpose":42,"observationalModel":38,"timePerspective":38,"maskingInfo":43},"RANDOMIZED","PARALLEL","TREATMENT",{"masking":44,"maskingDescription":38,"whoMasked":38},"NONE",[46,52],{"label":47,"type":48,"description":49,"interventionNames":50},"Control","PLACEBO_COMPARATOR","Receives standard of care, regular education in the clinic.",[51],"Behavioral: Standard Education",{"label":53,"type":54,"description":55,"interventionNames":56},"Continuous Glucose Monitoring Academy","EXPERIMENTAL","Receive an interactive workbook with problem-based learning scenarios and video links about Continuous Glucose Monitoring and glucose management strategies (CGM Academy Program). Participate in four in-depth online group sessions with diabetes care and education specialists complete questionnaires three times: at the time of study enrollment, week 4 and 6 months.",[57,51],"Behavioral: Continuous Glucose Monitoring Academy",[59,63],{"type":60,"name":53,"description":61,"armGroupLabels":62,"otherNames":38},"BEHAVIORAL","Educational materials as well as online sessions with diabetes educators.",[53],{"type":60,"name":64,"description":65,"armGroupLabels":66,"otherNames":67},"Standard Education","Standard of care receives general education about diabetes.",[53,47],[68],"Standard of Care",[70],{"name":71,"affiliation":5,"role":72},"Rebecca Barber, PhD, RN","PRINCIPAL_INVESTIGATOR",[74,79],{"name":75,"role":76,"phone":77,"phoneExt":38,"email":78},"Natalia Garban","CONTACT","3233611359","ngarban@chla.usc.edu",{"name":80,"role":76,"phone":77,"phoneExt":38,"email":81},"Rebecca Barber","rbarber@chla.usc.edu",[83],{"facility":5,"status":84,"city":85,"state":86,"zip":87,"country":88,"countryCode":89,"cosmosGeoPoint":90,"geoPoint":95,"contacts":96},"RECRUITING","Los Angeles","California","90027","United States","US",{"type":91,"coordinates":92},"Point",[93,94],-118.24368,34.05223,{"lat":94,"lon":93},[97,98],{"name":75,"role":76,"phone":38,"phoneExt":38,"email":78},{"name":71,"role":72,"phone":38,"phoneExt":38,"email":38},{"type":72,"investigatorFullName":100,"investigatorTitle":101,"investigatorAffiliation":5,"oldNameTitle":38,"oldOrganization":38},"Barber, Rebecca","Nurse Scientist",[103],{"name":104,"class":105},"National Institute on Minority Health and Health Disparities (NIMHD)","NIH","100555788",false,"NCT06516640","Type 2 Continuous Glucose Monitoring Academy","Randomized Control Trial Evaluating the Impact of Continuous Glucose Monitoring Academy Education Curriculum Versus Standard Care on Glycemic Outcomes for Youth With Type 2 Diabetes","Inclusion Criteria:\n\n1. Current age of 8-21 years;\n2. T2D diagnosis;\n3. Able to speak, read, and write English or Spanish\n\nExclusion Criteria:\n\na. Known history of medical adhesive allergies;","ALL","8 Years","21 Years",{"count":116,"type":117},60,"ESTIMATED","INTERVENTIONAL",[120],"NA","The goal of this clinical trial is to evaluate the Impact of Continuous Glucose Monitoring Academy Education Curriculum Versus Standard Care on Glycemic Outcomes for Youth With Type 2 Diabetes (T2D):\n\n* The first aim is to determine how feasible it is to adapt the Continuous Glucose Monitoring Academy curriculum to teach youth with T2D glucose management strategies.\n* The second aim is to evaluate the effects of the Continuous Glucose Monitoring Academy metrics.\n* The third aim is to explore the relationships between these metrics with diabetes distress, diabetes family responsibilities, and process metrics.\n\nParticipants will join for a total of four weeks of education, followed by a six-month clinical review. They will have access to an online workbook and videos, and will participate in virtual sessions with a diabetes educator who will cover glucose management strategies in-depth. Participants will wear their preferred Continuous Glucose Monitoring system (Dexcom or FreeStyle Libre) provided via insurance and inserted at the baseline visit.",[123],"Type 2 Diabetes",[125,126,127,123],"Continuous Glucose Monitoring","Glycemic Control","Diabetes Education","2026-02-04",{"date":130,"type":131},"2026-02-06","ACTUAL",{"date":133,"type":131},"2025-06-23",{"date":135,"type":117},"2026-12-30",{"name":5,"class":6},1]